Hiramoto, M <br/><br/>
Nuclear targeted suppression of NF-kappa B activity by the novel quinone derivative E3330.  [electronic resource] 

 -  Journal of immunology (Baltimore, Md. : 1950)  Jan 1998 
 - 810-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0022-1767 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Benzoquinones--pharmacokinetics<br/>Biological Transport--drug effects<br/>Cell Nucleus--drug effects<br/>DNA--drug effects<br/>DNA-Binding Proteins--metabolism<br/>Humans<br/>I-kappa B Proteins<br/>Jurkat Cells<br/>NF-KappaB Inhibitor alpha<br/>NF-kappa B--antagonists & inhibitors<br/>Phosphorylation--drug effects<br/>Propionates--pharmacokinetics<br/>Protein Binding--drug effects<br/>Subcellular Fractions--metabolism<br/>Transcription Factor RelA<br/>Transcription, Genetic--drug effects